BMG LABTECH is proud to announce that the fourth SPECTROstar Nano will
be going to Finland to aid in developing a discovery platform for pharmaceutical
nanoparticles at the University of Helsinki. "The discovery platform for
pharmaceutical nanoparticles relies on an unconventional combination of modern
methods. It will open important new horizons and it is expected to
fundamentally renew the field of drug delivery."
Dr. Marco Casteleijn further explains: "Specific experiments could
benefit greatly by the use to the SPECTROstar Nano due to its fast reading
times, robotic interface mode, low volume measurements, plate reading
capabilities, shaking and incubating capabilities, and full spectrum readout.
In addition, gas vent for atmospheric control could be useful for other
applications in the future, in case of automated growth and control of
mammalian cell lines. In addition, model drug concentrations such as calcein,
small lipophilic molecules (e.g. rhodamine B), siRNA and pDNA can be evaluated
by the SPECTROstar Nano (i.e. full spectrum, small volumes of 2 μL) during the
formulation process. "
To read his unique proposal visit
http://www.bmglabtech.com/promotion/fourth-winner.cfm
BMG LABTECH will be awarding the last of five SPECTROstar Nanos on
July 30, 2011. Just submit a short 2-4 page proposal explaining how your lab
would benefit from this new and innovative absorbance microplate, cuvette and
low-volume readers before the final deadline, July 15, 2011. If you would like to be the final winner,
tell BMG LABTECH how you propose to use the SPECTROstar Nano in a unique fashion
or proposing to use one of the instrument's many unique features such as: full
UV/Vis spectrum per well, gas vent for atmospheric control, 1536-well plate
reading capability, incubation and shaking, reference corrections to improve
data, cuvette and plate kinetics, BMG
LATECH's low volume LVis Plate, or robotic interface mode.
For more information go to
www.bmglabtech.com/promotion or ask your local BMG
LABTECH representative.
